Tom Price Tripled His Investment in Biomedical Firm With Sale of Stock Dr. Price sold shares in Innate Immunotherapeutics in February for $320,000, or some $225,000 more than his $94,000 investment, according to disclosure reports. https://t.co/Zejq7TTWRS